Clinical Trials Browser

Interventional × figitumumab × Clear all

NCT00872404 2016-04-20

A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Phase 2 Terminated

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT00372996 2015-10-28

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Phase 2 Terminated

219 enrolled 11 charts

Breast Neoplasms

NCT00560235 2015-10-28

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Phase 1/2 Completed

138 enrolled 15 charts

Ewing's Sarcoma Family of Tumors

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Phase 2 Withdrawn

Breast Diseases, Breast Neoplasms

NCT00635245 2015-03-11

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Phase 1 Withdrawn

Breast Neoplasms

NCT00907504 2014-06-17

ADVIGO1017

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT00729833 2014-06-09

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

Phase 1 Terminated

45 enrolled 18 charts

Other solid neoplasm

Advanced Cancer

NCT00596830 2014-01-13

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Phase 3 Terminated

681 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell

NCT00474760 2013-12-17

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Phase 1 Completed

65 enrolled 35 charts

Sarcoma, Ewing

NCT00976508 2013-12-13

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Phase 1 Terminated

24 enrolled 10 charts

BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT00927966 2013-11-14

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Phase 1 Completed

Sarcoma

NCT00147537 2013-10-30

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

Phase 1/2 Completed

282 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

NCT01653158 2013-10-30

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Phase 1 Completed

46 enrolled 34 charts

Advanced Non-Hematologic Malignancies

NCT00673049 2013-07-24

NSCLC

Phase 3 Terminated

583 enrolled 11 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00313781 2013-04-11

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Phase 2 Completed

204 enrolled 12 charts

Prostatic Neoplasms

NCT00603538 2013-04-11

Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

Phase 1 Completed

19 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT00560573 2013-03-21

Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

46 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT01536145 2013-03-15

CP-751,871 Treatment For Patients With Multiple Myeloma

Phase 1 Completed

47 enrolled 12 charts

Multiple Myeloma

NCT00977561 2013-02-25

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 7 charts

Small Cell Lung Carcinoma